Oral Appliance Effectiveness and Patient Satisfaction with Obstructive Sleep Apnea Treatment in Adults.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
18 Jan 2019
Historique:
entrez: 19 1 2019
pubmed: 19 1 2019
medline: 27 3 2019
Statut: epublish

Résumé

BACKGROUND Indication of oral appliances for the treatment of an obstructive sleep apnea (OSA) includes both patients with primary snoring and mild OSA, as well as patients with moderate to severe OSA who refuse other treatment or in whom such treatment failed. The aim of this study was to verify the effectiveness of current OSA treatment by objective measurements, and to assess by means of a questionnaire patients' satisfaction with oral appliances manufactured in our laboratory. MATERIAL AND METHODS The study enrolled 58 adult patients (40 men, 18 women) with mean age of 50.5 years; most were overweight or had class I obesity; mean baseline apnea-hypopnea index (AHI) value prior to the beginning of treatment was 31.3, range 0.6-71. RESULTS Average AHI reduction in the entire group was 10.4; 31% of patients experienced AHI reduction by at least 50%. Significant AHI reduction was proven when using the appliance. Appliances affect the reduction of AHI and patients tolerate the appliances well. CONCLUSIONS Oral appliances complement positive-pressure treatment and do not interfere with it in any way. Craniometric parameters seem to be applicable as predictors of success or failure of appliance treatment.

Identifiants

pubmed: 30655499
pii: 911242
doi: 10.12659/MSM.911242
pmc: PMC6346846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-524

Références

Chest. 2002 Aug;122(2):569-75
pubmed: 12171833
Chest. 2002 Sep;122(3):871-7
pubmed: 12226026
Am J Respir Crit Care Med. 2002 Sep 15;166(6):855-9
pubmed: 12231497
Evid Based Med. 2008 Feb;13(1):12
pubmed: 18234920
Eur Respir J. 2009 Oct;34(4):914-20
pubmed: 19324954
Sleep Breath. 2012 Mar;16(1):47-58
pubmed: 21424283
Am J Respir Crit Care Med. 2013 Apr 15;187(8):879-87
pubmed: 23413266
J Clin Sleep Med. 2014 Feb 15;10(2):215-27
pubmed: 24533007
Cranio. 2014 Oct;32(4):254-9
pubmed: 25252763
J Clin Sleep Med. 2015 Jul 15;11(7):773-827
pubmed: 26094920
J Oral Rehabil. 2016 Apr;43(4):249-58
pubmed: 26707632
Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):905-9
pubmed: 8143054
Chest. 1996 May;109(5):1269-75
pubmed: 8625679
Thorax. 1997 Apr;52(4):362-8
pubmed: 9196520

Auteurs

Marketa Skalna (M)

Obesitology Research Center, Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

Vilen Novak (V)

Department of Pediatric Neurology, University Hospital Ostrava, Ostrava, Czech Republic.

Marek Buzga (M)

Obesitology Research Center, Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

Pavel Skalny (P)

Department of Mathematics, VSB - Technical University of Ostrava, Ostrava, Czech Republic.

Jaroslava Hybaskova (J)

Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, Ostrava, Czech Republic.

Jiri Stransky (J)

Department of Oral and Maxillofacial Surgery, University Hospital Ostrava, Ostrava, Czech Republic.

Jan Stembirek (J)

Department of Oral and Maxillofacial Surgery, University Hospital Ostrava, Ostrava, Czech Republic.
Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics CAS, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH